GF
NAGE

Gabelli Funds’s Niagen Bioscience NAGE Stock Holding History

Gabelli Funds’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$790K Buy
247,500
+32,815
+15% +$133K 0.01% 980
2026
Q1 		$947K Buy
214,685
+10,685
+5% +$57.7K 0.01% 909
2025
Q4 		$1.3M Buy
204,000
+16,500
+9% +$115K 0.01% 848
2025
Q3 		$1.75M Sell
187,500
-2,400
-1% -$24.2K 0.01% 791
2025
Q2 		$2.74M Sell
189,900
-14,900
-7% -$147K 0.02% 661
2025
Q1 		$1.41M Buy
204,800
+14,800
+8% +$93K 0.01% 715
2024
Q4 		$1.01M Sell
190,000
-10,000
-5% -$54.7K 0.01% 783
2024
Q3 		$730K Hold
200,000
– – 0.01% 841
2024
Q2 		$546K Hold
200,000
– – ﹤0.01% 883
2024
Q1 		$696K Hold
200,000
– – 0.01% 845
2023
Q4 		$286K Buy
200,000
+20,000
+11% +$27.9K ﹤0.01% 960
2023
Q3 		$263K Buy
180,000
+15,000
+9% +$23.4K ﹤0.01% 984
2023
Q2 		$259K Buy
165,000
+8,200
+5% +$12.2K ﹤0.01% 990
2023
Q1 		$240K Buy
156,800
+104,800
+202% +$187K ﹤0.01% 1017
2022
Q4 		$87.4K Buy
52,000
+24,000
+86% +$38.1K ﹤0.01% 1112
2022
Q3 		$34K Buy
+28,000
New +$45.1K ﹤0.01% 1227

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Gabelli Funds's NAGE Position: Q2 2026 in Review

Gabelli Funds increased its Niagen Bioscience (NAGE) stake by 15% in Q2 2026, buying an estimated $133K and bringing the position to 247,500 shares worth $790K. The position accounts for 0.01% of the portfolio, ranked #980.

Gabelli Funds first reported a position in NAGE in Q3 2022 and has held it in 16 quarters since. The position peaked at $2.74M in Q2 2025. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Gabelli Funds held 247,500 shares of Niagen Bioscience worth $790K as of Q2 2026.
  • Gabelli Funds bought 32,815 Niagen Bioscience shares in Q2 2026, an estimated $133K.
  • Niagen Bioscience made up 0.01% of Gabelli Funds's portfolio in Q2 2026, its #980 holding.
  • Gabelli Funds first reported a position in Niagen Bioscience in Q3 2022 and has held it in 16 quarters since.
  • Gabelli Funds's Niagen Bioscience position peaked at $2.74M in Q2 2025.
  • 140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.